Mr. Speaker, we have been absolutely clear that we have a plan to support Canadians. It is a made-in-Canada initiative to support made-in-Canada solutions.
That is why we are proud to have invested in AbCellera, from Vancouver; VIDO-InterVac, from Saskatoon; Variation Biotechnolgies, from Ottawa; Medicago, from Quebec City; the National Research Council's Royalmount facility in Montreal; and ImmunoVaccine Technologies, in Dartmouth.
These are examples of the made-in-Canada solutions that are part of our plan to support Canadians to make sure they have access to safe and secure vaccines.